Jim Cramer: This Health Care Stock Is Pure Spec, The Only Neocloud I Like Is...
Cramer calls Nuvation Bio a pure spec, prefers CoreWeave over IREN, is unsure on Seneca, cautious on NuScale, and approves Box.
Read original at benzingaStocks · News reference
BTIG analyst Gregory Lewis reiterates IREN (NASDAQ:IREN) with a Buy and maintains $80 price target.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Cramer calls Nuvation Bio a pure spec, prefers CoreWeave over IREN, is unsure on Seneca, cautious on NuScale, and approves Box.
Read original at benzingaOpenAI's Sam Altman warns the AI infrastructure boom may be unsustainable, putting speculative neoclouds plays at risk.
Read original at benzinga